Advertisement

Covetrus, Inc. CVET

Set alert

Price alert · CVET

All alert types
20.99 0.00 0.00%

At close · Oct 12

20.93 Day range 21.00

52-week range unavailable

Open
20.93
Prev close
20.99
Mkt cap
2.94B
Vol
5.30M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
20.93
High
21.00
Forward P/E
16.27
Beta
1.51
Short ratio
2.70
Inst. own
95.21%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2022
50-d avg
20.87
200-d avg
18.85
1y target
22.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 4, 2021Earnings: —; estimate 0.23; surprise —%
  • Feb 24, 2022Earnings: —; estimate 0.25; surprise —%
  • May 5, 2022Earnings: —; estimate 0.23; surprise —%
  • May 23, 2022Downgrade: Raymond James · Outperform → Market Perform
  • May 23, 2022Rating: Morgan Stanley · — → Equal-Weight
  • May 25, 2022Downgrade: William Blair · Outperform → Market Perform
  • May 26, 2022Downgrade: Barclays · Overweight → Equal-Weight
  • Jun 13, 2022Downgrade: Stifel · Buy → Hold
  • Aug 4, 2022Earnings: —; estimate 0.26; surprise —%
  • Aug 25, 2022Rating: Goldman Sachs · — → Sell
Signals (28)
NameDateAgo
MACD: Buy SignalOct 11, 20224 years ago
RSI: OverboughtJul 1, 20224 years ago
MACD: Sell SignalJun 10, 20224 years ago
RSI: OverboughtMay 25, 20224 years ago
SMA: BullishMay 16, 20224 years ago
MACD: Buy SignalMay 6, 20224 years ago
MACD: Sell SignalMay 5, 20224 years ago
MACD: Buy SignalMay 4, 20224 years ago
MACD: Sell SignalApr 22, 20224 years ago
MACD: Buy SignalApr 21, 20224 years ago
MACD: Sell SignalApr 6, 20224 years ago
SMA: BearishMar 30, 20224 years ago
SMA: BullishMar 29, 20224 years ago
MACD: Buy SignalMar 24, 20224 years ago
MACD: Sell SignalMar 7, 20224 years ago
SMA: BearishFeb 28, 20224 years ago
MACD: Buy SignalFeb 28, 20224 years ago
SMA: BullishFeb 25, 20224 years ago
MACD: Sell SignalFeb 18, 20224 years ago
SMA: BearishFeb 17, 20224 years ago
SMA: BullishFeb 15, 20224 years ago
SMA: BearishFeb 10, 20224 years ago
SMA: BullishFeb 8, 20224 years ago
SMA: BearishFeb 2, 20224 years ago
SMA: BullishFeb 1, 20224 years ago
MACD: Buy SignalJan 28, 20224 years ago
SMA: BearishJan 12, 20224 years ago
MACD: Sell SignalJan 5, 20224 years ago

Key statistics

Market cap
2.94B
Enterprise value
4.07B
Trailing P/E
0.00
Forward P/E
16.27
PEG ratio
1.59
Price / sales
0.63
Price / book
1.95
EPS (TTM)
-0.30
Beta
1.51
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-0.28%
Revenue (TTM)
4.65B
Revenue growth
2.40%
Free cash flow
63.50M
Total cash
87.00M
Total debt
1.19B
Return on equity
-0.85%
Shares outstanding
140.12M
Short % of float
4.21%
50-day average
20.87
200-day average
18.85

Analyst view

Consensus: hold

Hold
Price target (mean) 22.00

Next earnings

Nov 3, 2022

Expected Nov 3, 2022. Consensus EPS estimate 0.28.

Earnings history

Financials — quick view

All financials
CVET Revenue — quarterly 1.22B
2018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 2022
CVET Net income — quarterly -4.00M
2018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 2022
CVET EPS — quarterly -0.03
2018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 2022

Earnings

CVET recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 3, 2022Sep 1, 20220.27———
Aug 4, 2022Jun 1, 20220.26———
May 5, 2022Mar 1, 20220.23———
Feb 24, 2022Dec 1, 20210.25———
Nov 4, 2021Sep 1, 20210.23———
Aug 5, 2021Jun 1, 20210.23———

Upgrades / downgrades

CVET analyst upgrades and downgrades
DateFirmActionFromTo
Jun 13, 2022StifeldownBuyHold
May 26, 2022BarclaysdownOverweightEqual-Weight
May 25, 2022William BlairdownOutperformMarket Perform
May 23, 2022Morgan Stanleymain—Equal-Weight
May 23, 2022Raymond JamesdownOutperformMarket Perform
Aug 25, 2022Goldman Sachsmain—Sell

About Covetrus, Inc.

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

Sector
Healthcare
Industry
Medical Distribution
Country
United States
Website
covetrus.com

News

Your note

Sign in to keep a note on CVET — it syncs with the Stock Master app.

Insider holders

CVET insider holders
InsiderRelationLatest transactionDateShares held
FINER DUSTIN KOfficerConversion of Exercise of derivative securityMay 31, 202289,370
FONTEYNE PAUL RDirectorConversion of Exercise of derivative securityJun 30, 202213,275
FOULSTON MATTHEW JChief Financial OfficerConversion of Exercise of derivative securityAug 31, 202295,079
HELTON SANDRA LYNNDirectorConversion of Exercise of derivative securityMay 11, 202238,095
KIDD REBECCA ANNOfficerConversion of Exercise of derivative securitySep 29, 202220,028
MALENFANT MATTHEWOfficerConversion of Exercise of derivative securityAug 31, 202284,304

Institution ownership

CVET institution ownership
Holder% heldSharesValueReported
Clayton, Dubilier & Rice, LLC24.07%33,732,300708.04MJun 29, 2022
Blackrock Inc.12.15%17,030,965357.48MJun 29, 2022
Vanguard Group, Inc. (The)8.32%11,657,622244.69MJun 29, 2022
Wellington Management Group, LLP5.98%8,372,908175.75MJun 29, 2022
State Street Corporation2.77%3,878,41981.41MJun 29, 2022
Dimensional Fund Advisors LP2.20%3,084,63964.75MJun 29, 2022

Fund ownership

CVET fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF5.45%7,636,624160.29MSep 29, 2022
Vanguard Total Stock Market Index Fund2.21%3,093,81864.94MJun 29, 2022
Vanguard Small-Cap Index Fund1.88%2,639,42355.40MJun 29, 2022
iShares Russell 2000 ETF1.64%2,298,61848.25MSep 29, 2022
Vanguard Small Cap Value Index Fund1.24%1,743,49936.60MJun 29, 2022
iShares S&P Smallcap 600 Value ETF1.05%1,471,09230.88MSep 29, 2022
Advertisement